Scientists with CRISPR gene editing technology have succeeded in preventing the corona virus from replicating in infected cells in the body. This method is currently successful in laboratory tests and is to be tested on animals soon.
In an article published in the journal Nature, a group of Australian researchers say they have been able to inhibit the replication of SARS-CoV-2 by using “Crisper” technology, which allows the manipulation of DNA sequences and the modification of gene function. Using the CRISPR-Cas13b enzyme, which binds to the RNA sequences of the corona virus, the group was able to destroy the genome needed for the virus to multiply in host cells.
It has previously been shown that Crisper technology can be used to remove genetic codes that can cause cancer in children. “Once the virus is found, the crisper enzyme is activated and kills the virus,” said Sharon Levine, lead author of the article.
This technique has also been successful in preventing the proliferation of disturbing species of the corona virus, including the alpha species. However, Levin has stated that we are probably still years away from launching such a method of treatment with Crisper technology. He believes that the best treatment is to take oral antiviral drugs, which can be prescribed to the patient as soon as Covid-19 is diagnosed.
However, such a method requires an effective, cheap and safe drug. Levin and his team hope to one day achieve this with genetic engineering. “The present study shows the potential of using Crisper technology in the treatment of other viral diseases,” said Mohammad Fareh, another author of the article. “Unlike conventional antiviral drugs, this tool has a high degree of flexibility and adaptability that makes this treatment possible.” “It turns out to be a good medicine for many viral diseases, including the flu, Ebola and maybe even HIV.”